Proteomics referred as the study of proteomes, which is a set of proteins that is produced in an organism, system, or any biological context. They may vary from cell to cell and changes over a specific period of time. They are used in various applications such as in transcriptional & post transcriptional studies, to investigate protein expression, metabolic pathways, to study localization of sub cellular proteins, to study protein interaction in diseases viz. cancer etc. Proteomics can be studied using various technologies including gel-based techniques, mass spectrometry, and others.
According to study, “Proteomics Market Global Report 2020-30” the key companies operating in the global proteomics market are Thermo Fisher Scientific, Inc.; Merck KGaA; Waters Corporation; Perkinelmer, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Bio-Rad Laboratories, IncCaprion Biosciences; Luminex Corporation; .; Bruker Corporation; GE Healthcare; LI-COR, Inc.; Siemens Ltd; Genzyme Corporation; Creative Proteomics; Becton, Dickinson and Company; Promega Corporation
Based on instrumentation
technology, proteomics market is segmented as spectroscopy, protein
microarrays, chromatography, x-ray crystallography, electrophoresis protein
fractionation and surface Plasmon resonance. Spectroscopy includes NMR spectroscopy,
mass spectroscopy, and CD spectroscopy. Protein microarrays include microarray
instruments (arrayers, integrated systems and microarray scanners) and biochips
(lab-on-chips and protein chips). Chromatography includes Ion chromatography,
HPLC, supercritical fluid chromatography and affinity chromatography. Electrophoresis includes capillary
electrophoresis and gel electrophoresis. Based on reagent, market is segmented
as spectroscopy reagents, immunoassay reagents, protein microarray reagents,
electrophoresis reagents, x-ray crystallography reagents, protein fractionation
reagents, chromatography reagents. Based on software & services, market is
segmented as bioinformatics software & services and core proteomics
services. Bioinformatics software & services are further sub-segmented as
bioinformatics tools, bioinformatics databases and bioinformatics services.
Core proteomics services are further sub-segmented as protein separation
services, protein identification services, protein sequencing services, custom
assay services, protein characterization services, quantitative proteomic
services and others. In addition, based on application, market is segmented as
clinical diagnostics (diabetes, cancer, cardiovascular diseases, infectious
diseases, immune diseases, neurological disorders and others), drug discovery
(preclinical studies, lead optimization, lead identification and target
discovery) and others.
The proteomics market is driven by
rise in demand for advanced diagnostics in targeted disease treatment, followed
by increase in geriatric population demanding personalized medicines, rise in
prevalence of target diseases and increase in pharmaceutical &
biotechnology Research & Development (R&D) expenditure and government
funding for proteomics. However, low biomarker discovery-to-approval ratio and
high cost of instruments may impact the market. Moreover, personalized
proteomics for precision health and growth in prominence of nanoproteomics are
key opportunities for market.
Based on geography, the North-American
region holds major share in global proteomics market owing to increase in
research activities, rise in government funding, improved healthcare
infrastructure, rise in awareness regarding applications of proteomics,
increase in prevalence of cancer and increase in health care expenditure in the
region. Whereas, the Asian-Pacific and European regions are anticipated to
witness higher growth rate due to increase in cancer research activities and
presence of key market players over the forecast period. It is estimated that
future of the global market will be optimistic as a result of presence of a
large number of drug manufactures globally during the forecast period. The
global proteomics market was valued at US $18.01 billion in 2019 and it is expected
to grow at a CAGR of 14.79% and reach at US $31.28 billion by 2023.
For More Information, Click on the Link Below:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing &
Communications
No comments:
Post a Comment